Silk fibroin hydrolysate ameliorates diabetic dyslipidemia in type 2 diabetic model mice

References

• Batra SP, Lark RH, Colman RF. 1989. Identification of histidyl peptide labeled by 2-(4-bromo-2,3-dioxobutylthio)adenosine 5′-monophosphate in an ADP regulatory site of glutamate dehydrogenase. Arch Biochem Biophys. 270:277–285. doi:10.1016/0003-9861(89)90029-5
   PubMed Web of Science ®Google Scholar
• Chen H, Charlat O, Tartaglia LA, Woolf EA, Weng X, Ellis SJ, Lakey ND, Culpepper J, Moore KJ, Breitbart RE, et al. 1996. Evidence that the diabetes gene encodes the leptin receptor: identification of a mutation in the leptin receptor gene in db/db mice. Cell. 84:491–495. doi:10.1016/S0092-8674(00)81294-5
   PubMed Web of Science ®Google Scholar
• Cheng AY, Fantus IG. 2005. Oral antihyperglycemic therapy for type 2 diabetes mellitus. CMAJ. 172:213–226. 10.1503/cmaj.1031414
   PubMed Web of Science ®Google Scholar
• Do SG, Park JH, Nam H, Kim JB, Lee JY, Oh YS, Suh JG. 2012. Anti-diabetic effect of silk fibroin hydrolysate via increasing pancreatic β cell mass in C57BL/KsJ-db/db mice. J Vet Sci. 13:339–344. 10.4142/jvs.2012.13.4.339
   Web of Science ®Google Scholar
• Forman LM, Simmons DA, Diamond RH. 2000. Hepatic failure in a patient taking rosiglitazone. Ann Intern Med. 132:118–121. 10.7326/0003-4819-132-2-200001180-00005
   PubMed Web of Science ®Google Scholar
• Garris DR, Garris BL. 2004. Cytochemical analysis of pancreatic islet hypercytolipidemia following diabetes (db/db) and obese (ob/ob) mutation expression: influence of genomic background. Pathobiology. 71:231–240. 10.1159/000080056
   PubMed Web of Science ®Google Scholar
• Hikino H, Mizuno T, Oshima Y, Konno C. 1985. Isolation and hypoglycemic activity of moran A, a glycoprotein of Morus alba root barks. Planta Med. 51:159–160. 10.1055/s-2007-969435
   Web of Science ®Google Scholar
• Hyun CK, Kim IY, Frost SC. 2004. Soluble fibroin enhances insulin sensitivity and glucose metabolism in 3T3-L1 adipocytes. J Nutr. 134:3257–3263.
   PubMed Web of Science ®Google Scholar
• Kim ES, Park SJ, Lee EJ, Kim BK, Huh H, Lee BJ. 1999. Purification and characterization of Moran 20K from Morus alba. Arch Pharm Res. 22:9–12. 10.1007/BF02976428
   PubMed Web of Science ®Google Scholar
• Kobayashi K, Forte TM, Taniguchi S, Ishida BY, Oka K, Chan L. 2000. The db/db mouse, a model for diabetic dyslipidemia: molecular characterization and effects of Western diet feeding. Metabolism. 49:22–31. 10.1016/S0026-0495(00)90588-2
   PubMed Web of Science ®Google Scholar
• Konno S, Tortorelis DG, Fullerton SA, Samadi AA, Hettiarachchi J, Tazaki H. 2001. A possible hypoglycemic effect of maitake mushroom on type 2 diabetic patients. Diabet Med. 18:1010. 10.1046/j.1464-5491.2001.00532-5.x
   PubMed Web of Science ®Google Scholar
• McGarry JD, Dobbins RL. 1999. Fatty acids, lipotoxicity and insulin secretion. Diabetologia. 42:128–138. 10.1007/s001250051130
   PubMed Web of Science ®Google Scholar
• Mooradian AD. 2009. Dyslipidemia in type 2 diabetes mellitus. Nat Clin Pract Endocrinol Metab. 5:150–159. 10.1038/ncpendmet1066
   PubMedGoogle Scholar
• Nam JH, Oh YS. 1995. A study of pharmacological effect of silk fibroin. Agric Sci. 37:145–157.
   Google Scholar
• Nesher R, Della Casa L, Litvin Y, Sinai J, Del Rio G, Pevsner B, Wax Y, Cerasi E. 1987. Insulin deficiency and insulin resistance in type 2 (noninsulin-dependent) diabetes: quantitative contributions of pancreatic and peripheral responses to glucose homeostasis. Eur J Clin Invest. 17:266–274. 10.1111/j.1365-2362.1987.tb01247.x
   PubMed Web of Science ®Google Scholar
• Newfield RS, Dewan AK, Jain S. 2008. Dyslipidemia in children with type 2 diabetes vs. obesity. Pediatr Diabetes. 9:115–121. 10.1111/j.1399-5448.2007.00345.x
   PubMed Web of Science ®Google Scholar
• Nishina PM, Lowe S, Wang J, Paigen B. 1994. Characterization of plasma lipids in genetically obese mice: the mutants obese, diabetes, fat, tubby, and lethal yellow. Metabolism. 43:549–553. 10.1016/0026-0495(94)90194-5
   PubMed Web of Science ®Google Scholar
• Obatomi DK, Bikomo EO, Temple VJ. 1994. Anti-diabetic properties of the African mistletoe in streptozotocin-induced diabetic rats. J Ethnopharmacol. 43:13–17. 10.1016/0378-8741(94)90111-2
   PubMed Web of Science ®Google Scholar
• Park JH, Nam Y, Park SY, Kim JK, Choe NH, Lee JY, Oh YS, Suh JG. 2011. Silk fibroin has a protective effect against high glucose induced apoptosis in HIT-T15 cells. J Biochem Mol Toxicol. 25:238–243. 10.1002/jbt.20381
   PubMed Web of Science ®Google Scholar
• Poitout V, Robertson RP. 2002. Minireview: secondary beta-cell failure in type 2 diabetes–a convergence of glucotoxicity and lipotoxicity. Endocrinology. 143:339–342. 10.1210/en.143.2.339.
   PubMed Web of Science ®Google Scholar
• Silver DL, Jiang X, Tall AR. 1999. Increased high density lipoprotein (HDL), defective hepatic catabolism of ApoA-I and ApoA-II, and decreased ApoA-I mRNA in ob/ob mice. Possible role of leptin in stimulation of HDL turnover. J Biol Chem. 274:4140–4146. 10.1074/jbc.274.7.4140
   PubMed Web of Science ®Google Scholar
• Watkins PB, Whitcomb RW. 1998. Hepatic dysfunction associated with troglitazone. N Engl J Med. 338:916–917. 10.1056/NEJM199803263381314
   PubMed Web of Science ®Google Scholar
• Zhou YP, Grill VE. 1994. Long-term exposure of rat pancreatic islets to fatty acids inhibits glucose-induced insulin secretion and biosynthesis through a glucose fatty acid cycle. J Clin Invest. 93:870–876. 10.1172/JCI117042
   PubMed Web of Science ®Google Scholar